Pruss U, Rose H K, Zechner A
Psychiatr Prax. 1984 Jul;11(4):101-8.
In recent years, depot neuroleptics have gained in importance in the outpatient treatment of chronic schizophrenics. These neuroleptics make drug therapy safer than before, thus improving the prerequisites for socio-therapeutic and rehabilitative measures. The present study analyses the ranking and value of this kind of treatment in the management of outpatients. A random sample of 80 schizophrenics treated as outpatients, by a psychiatric university clinic working on a sectorial basis was examined for the purpose of this study. Treatment results, problems of indication, limitations of therapeutic possibilities using depot neuroleptics, as well as constellative conditions under which therapy was discontinued, are discussed.
近年来，长效抗精神病药物在慢性精神分裂症患者的门诊治疗中变得愈发重要。这些抗精神病药物使药物治疗比以往更安全，从而改善了社会治疗和康复措施的前提条件。本研究分析了此类治疗在门诊管理中的排名和价值。为了本研究的目的，对一所按部门运作的大学精神病诊所作为门诊治疗的80名精神分裂症患者的随机样本进行了检查。讨论了治疗结果、适应症问题、使用长效抗精神病药物治疗可能性的局限性以及治疗中断时的相关情况。
